Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Journal Article

Waldschmidt, D., Merle, P., Granito, A., Huang, Y-H, Bodoky, G., Yokosuka, O., Rosmorduc, O., Breder, V. V., Gerolami, R., Masi, G., Ross, P. J., Qin, S., Song, T., Bronowicki, J-P, Ollivier-Hourmand, I, Kudo, M., Xu, L., Baumhauer, A., Meinhardt, G., Han, G. and Bruix, J. (2018). Hand-foot skin reaction (HFSR) and overall survival (OS) in the phase 3 RESORCE trial of regorafenib for treatment of hepatocellular carcinoma (HCC) progressing on sorafenib. Oncol. Res. Treat., 41. S. 281 - 282. BASEL: KARGER. ISSN 2296-5262

Waldschmidt, D., Teufel, M., Koechert, K., Meinhardt, G. and Bruix, J. (2018). Efficacy of regorafenib (REG) in patients with hepatocellular carcinoma (HCC) in the phase III RESORCE trial according to alpha-fetoprotein (AFP) and c-Met levels as predictors of poor prognosis. Oncol. Res. Treat., 41. S. 281 - 283. BASEL: KARGER. ISSN 2296-5262

This list was generated on Sat Mar 6 03:01:47 2021 CET.